PRISM PHARMA CO., LTD.
Patent Owner
Stats
- 4 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Sep 21, 2017 most recent publication
Details
- 4 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 49 Total Citation Count
- Jun 05, 2009 Earliest Filing
- 10 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9174998 (6S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-8-({6-[3-(piperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-2-(prop-2-en-1-yl)-octahydro-1H-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide compoundDec 19, 14Nov 03, 15[A61K, C07F, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0318,938 CRYSTALS (2) OF PYRAZINO[2,1-c][1,2,4]TRIAZINE COMPOUNDAbandonedDec 22, 14Nov 03, 16[C07D]
2016/0318,957 CRYSTAL (1) OF PYRAZINO[2,1-c][1,2,4]TRIAZINE COMPOUNDAbandonedDec 22, 14Nov 03, 16[C07F]
2016/0244,453 TREATMENT OF VIRAL AND INFECTIOUS DISEASES USING AN INHIBITOR OF CBP/CATENINAbandonedOct 21, 13Aug 25, 16[A61K, C07F, C07D]
2016/0215,007 METHOD OF PRODUCING PYRAZINO[2,1-C][1,2,4]TRIAZINE COMPOUNDAbandonedSep 09, 14Jul 28, 16[C07F]
2016/0166,577 TREATMENT OF PULMONARY FIBROSIS USING AN INHIBITOR OF CBP/CATENINAbandonedOct 21, 13Jun 16, 16[A61K]
2015/0283,145 TREATMENT OF HYPERPROLIFERATIVE AND PRE-CANCEROUS SKIN DISEASES USING AN INHIBITOR OF CBP/CATENINAbandonedOct 21, 13Oct 08, 15[A61K]
2015/0274,751 TREATMENT OF SCLERODERMA USING AN INHIBITOR OF CBP/CATENINAbandonedOct 21, 13Oct 01, 15[C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.